Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
01 10Bayer Inc.
01 52485143
02 52936852
01 10Riociguat
01 8Tablet
02 2Tablets
01 52023-04-25
02 52030-11-22
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2023-04-25
Date Granted : 2011-04-19
Brand Name : ADEMPAS
Patent Number : 2485143
Filing Date : 2003-04-25
Strength per Unit : 0.5 mg
Dosage Form : Tablets
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-04-25
Date Granted : 2011-04-19
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2023-04-25
Date Granted : 2011-04-19
Brand Name : ADEMPAS
Patent Number : 2485143
Filing Date : 2003-04-25
Strength per Unit : 1 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-04-25
Date Granted : 2011-04-19
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2023-04-25
Date Granted : 2011-04-19
Brand Name : ADEMPAS
Patent Number : 2485143
Filing Date : 2003-04-25
Strength per Unit : 1.5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-04-25
Date Granted : 2011-04-19
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2023-04-25
Date Granted : 2011-04-19
Brand Name : ADEMPAS
Patent Number : 2485143
Filing Date : 2003-04-25
Strength per Unit : 2 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-04-25
Date Granted : 2011-04-19
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2023-04-25
Date Granted : 2011-04-19
Brand Name : ADEMPAS
Patent Number : 2485143
Filing Date : 2003-04-25
Strength per Unit : 2.5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-04-25
Date Granted : 2011-04-19
Patent Expiration Date : 2030-11-22
Date Granted : 2019-10-29
Brand Name : ADEMPAS
Patent Number : 2936852
Filing Date : 2010-11-22
Strength per Unit : 0.5 mg
Dosage Form : Tablets
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2030-11-22
Date Granted : 2019-10-29
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2030-11-22
Date Granted : 2019-10-29
Brand Name : ADEMPAS
Patent Number : 2936852
Filing Date : 2010-11-22
Strength per Unit : 1 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2030-11-22
Date Granted : 2019-10-29
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2030-11-22
Date Granted : 2019-10-29
Brand Name : ADEMPAS
Patent Number : 2936852
Filing Date : 2010-11-22
Strength per Unit : 1.5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2030-11-22
Date Granted : 2019-10-29
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2030-11-22
Date Granted : 2019-10-29
Brand Name : ADEMPAS
Patent Number : 2936852
Filing Date : 2010-11-22
Strength per Unit : 2 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2030-11-22
Date Granted : 2019-10-29
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2030-11-22
Date Granted : 2019-10-29
Brand Name : ADEMPAS
Patent Number : 2936852
Filing Date : 2010-11-22
Strength per Unit : 2.5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2030-11-22
Date Granted : 2019-10-29
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
